Charles River Laboratories
James C. Foster is Chairman of the Board, President, and Chief Executive Officer of Charles River Laboratories, a leading provider of essential products and services that fully support the drug discovery and early-stage development process. Since beginning his career at Charles River in 1976, Mr. Foster has held a variety of positions including: Vice President of Administration and General Counsel, President of Charles River Biotechnical Services, and Executive Vice President, Charles River. Mr. Foster was named President in 1991, Chief Executive Officer (CEO) in 1992, and Chairman in 2000.
As CEO, Mr. Foster has built Charles River from a niche research models and services business to a full service, early-stage drug research partner to more than 100 of the world’s largest biopharmaceutical companies and academic institutions, as well as thousands of emerging and established biotechnology companies. Today, the Company offers a unique portfolio of products and services required to take a novel drug therapy from discovery through non-clinical development.
Mr. Foster is a Senior Advisor at Cell Signaling Technology. He is Chairman of the Board of Trustees of the Institute of Contemporary Art in Boston, and a member of the Presidential Advisory Council for Berklee College of Music. He is a guest lecturer at the Massachusetts Institute of Technology (MIT).
This person is not in any offices
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.